Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignancies

We retrospectively evaluated the tolerability and efficacy of fractionated total body irradiation (TBI) (1,200 cGy) and melphalan (MEL) (100–110 mg/m(2)) myeloablative conditioning in 48 patients with nonremission AML (n = 14), ALL (n = 10), NHL (n = 18), and other refractory hematologic malignancie...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatnagar, Bhavana, Rapoport, Aaron P., Fang, Hong-Bin, Ilyas, Can, Marangoz, Deniz, Akbulut, Vinil, Ruehle, Kathleen, Badros, Ashraf, Yanovich, Saul, Akpek, Görgün
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101620/
https://www.ncbi.nlm.nih.gov/pubmed/24097082
http://dx.doi.org/10.1007/s00277-013-1908-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101620/
https://www.ncbi.nlm.nih.gov/pubmed/24097082
http://dx.doi.org/10.1007/s00277-013-1908-9

Ejemplares similares